Response to Comment on “Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women”

GSTDTAP > 气候变化

DOI	10.1126/science.abj7375
	Response to Comment on “Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women”
	Samuel Klein; Mihoko Yoshino
	2021-07-30
发表期刊	Science
出版年	2021
英文摘要	In evaluating any randomized clinical trial, it is important to determine whether baseline differences between groups could have affected the primary outcome. In our study, muscle insulin sensitivity, which was identical in both groups at baseline, improved after nicotinamide mononucleotide (NMN), not placebo, therapy. Differences in baseline intrahepatic triglyceride content between groups do not negate the effects of NMN observed in muscle.
领域	气候变化 ; 资源环境
URL	查看原文
引用统计
文献类型	期刊论文
条目标识符	http://119.78.100.173/C666/handle/2XK7JSWQ/335548
专题	气候变化资源环境科学
推荐引用方式 GB/T 7714	Samuel Klein,Mihoko Yoshino. Response to Comment on “Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women”[J]. Science,2021.
APA	Samuel Klein,&Mihoko Yoshino.(2021).Response to Comment on “Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women”.Science.
MLA	Samuel Klein,et al."Response to Comment on “Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women”".Science (2021).